SYDE2
protein-codingsynapse defective Rho GTPase homolog 2, the group of C2 domain containing
Gene summary
Predicted to enable GTPase activator activity. Acts upstream of or within cell migration. Predicted to be located in cytosol. Predicted to be active in synaptic membrane. [provided by Alliance of Genome Resources, Jul 2025]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~44.8 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0019042
Submitter: Ambry Genetics
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SYDE2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_032184.2. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 1 | 2 | |||
| missense | 150 | 10 | 3 | 163 | ||
| nonsense | 1 | 1 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 1 | 1 | ||||
| Total | 0 | 0 | 153 | 10 | 4 | 167 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_115560.1 | 7 | MANE Select | |
| Ensembl | ENSP00000340594.5 | 7 | MANE Select | |
| Ensembl | ENSP00000512715.1 | 7 | Standard | |
| Ensembl | ENSP00000512715.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Signal Transduction
- Rho GTPase cycle
- Signaling by Rho GTPases
Biological Process
- signal transduction
- regulation of small GTPase mediated signal transduction
- activation of GTPase activity
Molecular Function
- GTPase activator activity
Cellular Component
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000341460
- Coding exons
- 7
- Length
- 44174
- Individuals with no LoFs
- 124006
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 633
- Defined
- 124641
- p
- 0.00255
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.787 | 531 | 585 | 0.908 | 0.0000278 | 7763 |
| Missense (PolyPhen) | 184 | 193.43 | 0.95123 | 2745 | ||
| Synonymous | 1.22 | 193 | 216 | 0.894 | 0.0000103 | 2340 |
| Loss of Function | 1.57 | 32 | 43.1 | 0.742 | 0.00000263 | 555 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00032 | 0.00032 | rare |
| Latino/Admixed American | 0.00099 | 0.00099 | rare |
| Ashkenazi Jewish | 0.0036 | 0.0036 | notable |
| East Asian | 0.0011 | 0.0011 | notable |
| Finnish | 0.012 | 0.012 | notable |
| European (Non-Finnish) | 0.0019 | 0.0019 | notable |
| South Asian | 0.0021 | 0.0020 | notable |
| Other | 0.0018 | 0.0018 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}.;
Recessive Scores
- pRec
- 0.125
Intolerance Scores
- LoFtool
- 0.975
- RVIS EVS
- 0.72
- RVIS percentile EVS
- 85.83
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.581
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |